OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Bladder cancer is any of several types of cancer arising from the epithelial lining of the urinary bladder, a balloon-shaped organ in your pelvic area that stores urine. Tobacco smoking is the main known contributor to urinary bladder cancer. Carcinogens such as nitrosamines are concentrated and excreted in the urine, thereby exposing them to the cells lining the urinary tract. This exposure is prolonged in the bladder (where 95% of urothelial carcinomas arise) but malignant transformation can arise anywhere in the urinary tract, from the renal calyx to the urethral meatus. Bladder cancer can be treated by surgery by removing tumor, tumor and a small portion of the bladder, biological therapy, removing the entire bladder, Chemotherapy, radiation therapy.
Symptoms: The presence of large numbers of abnormal cells in the bone marrow can inhibit the marrow from producing normal healthy blood cells. Symptoms caused by bone marrow failure include paleness, tiredness, shortness of breath, excessive bleeding, and increased susceptibility to infections. Cancer cells can also infiltrate organs such as the lymph nodes, spleen, and liver leading to swelling.
Treatment: Herbal deals in leukemia/blood cancer cure: Certain herbs, at least two varieties of herbs known by the names of 'Garcinia Mangostana' and 'xanothenes' have been found to be effective with respect of leukemia. The herbs and compounds based on them have reflected intrinsic potential of growth inhibiting features.
Statistics: Bladder cancer is the seventh most common cause of cancer death in the UK. Around 5,200 people died from bladder cancer in 2012 in the UK, that's 14 people every day. Since the early 1990s, bladder cancer death rates in the UK have decreased by more than a third for men and by around a quarter for women. In Europe, around 52,400 people were estimated to have died from bladder cancer in 2012. The UK mortality rate is 10th lowest in Europe for males and eighth highest for females.
